ArticleOpen forum infectious diseases2023

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.

Kwabena Asare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.